GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation
Issued: Wednesday 30 March 2011, London UK - Litigation continues between Pronova BioPharma and two other generic challengers GlaxoSmithKline (GSK), which has the marketing rights for Lovaza (omega-3-acid ethyl esters) in the US and Puerto Rico …